lung cancer gene and literature database Home
Cancer metastasis database

Annotation category 5

Literatures

Literature evidence

Links to all GeneRIF Items

3725

PubMed (Gene Name)

Literature evidence

16158054 (JUN)

Dysregulated c-jun expression may be involved in the acquisition of anchorage independence in the process of human lung carcinogenesis

19018257 (JUN)

AP-1 and PI3K/Akt pathways play an essential role in the growth of somenon-small cell lung cancer cells

20331627 (JUN)

decrease of lung cancer cell proliferation by ZAK may involve the ERK and JNK pathways via an AP-1 transcription factor.

21081043 (JUN)

The expression of COX-2 was significantly associated with the expressions of transcription factors NFAT3 and c-Fos in nonsmall cell lung cancer.

21972703 (JUN)

The increased levels of ICAM-1 and C-Jun are negative prognostic factors for the patients with non-small cell lung cancer.

22189957 (JUN)

Genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer.

22438909 (JUN)

Blimp1 is a mediator of Ras/Raf/AP-1 signaling that promotes cell migration, and is repressed by LOX-PP in lung cancer.

23182717 (JUN)

Data show that a photodynamic therapy (PDT) dose-dependent upregulation of CRP gene, as well as of PTX3 and ficolin 1 genes in lung tumor A549 cells, and indicate critical role played by PI3K/Akt/AP-1 pathway.

27424491 (JUN)

This is the first study to show how TGF-beta regulates the expression of Claudin-4 through c-Jun signaling and how this pathway contributes to the migratory and tumorigenic phenotype of lung tumor cells.

28566434 (JUN)

These findings suggest that increased JUN expression and activity may contribute to gefitinib resistance in non-small cell lung cancer.

28618937 (JUN)

Our results suggest that hypoxia-elicited c-Jun/activator protein 1 regulates 37-kDa laminin receptor precursor expression, which modulates migration and invasion of lung adenocarcinoma cells.

29362431 (JUN)

transcription factor c-Jun bound to the promoter region of human miR-374a and suppressed miR-374a in A549 and pc-9 cells while inducing it in SPCA-1 and H1975 cells. Increased levels of miR-374a appeared to serve a protective role by targeting CCND1 in early-stage non-small-cell lung cancer.

32950569 (JUN)

AMOTL2 inhibits JUN Thr239 dephosphorylation by binding PPP2R2A to suppress the proliferation in non-small cell lung cancer cells.

20716630 (Jun)

TAM67 (mutant of c-jun) decreased tumor number and overall lung tumor burden in chemically induced mouse lung tumor models.